Lv3
320 积分 2022-09-05 加入
SLC22A1 resists HBV by activating JAK/STAT pathway and predicts effect of pegIFNα-based therapy on CHB
1天前
待确认
Coexistence of hepatitis B e antigen and antibody during antiviral treatment predicts better clinical outcomes in children
18天前
已完结
Targeting ferroptosis restores the antiviral activity of CD8+ T cells during chronic HBV infection
22天前
已完结
Discovery of VNRX-9945, a Potent, Broadly Active Capsid Assembly Modulator as a Clinical Candidate for the Treatment of Chronic Hepatitis B Virus Infection
1个月前
已完结
Scientific and medical evidence informing expansion of hepatitis B treatment guidelines
1个月前
已完结
A Double‐Blind, Placebo‐Controlled, Single‐Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT‐101, an RNAi Therapeutic Targeting HBV Infection
1个月前
已完结
Patient and public health perspectives to inform expansion of hepatitis B treatment guidelines
1个月前
已关闭
Scoping Review on Strategies for Safe Nucleot(s)ide Analogue Discontinuation and Optimising Functional Cure in Chronic Hepatitis B
1个月前
已完结
High-Throughput Viral Integration Detection Reveals Baseline Breakpoints Burden Associated With HBsAg Seroclearance
1个月前
已完结
High-Throughput Viral Integration Detection Reveals Baseline Breakpoints Burden Associated With HBsAg Seroclearance
1个月前
已完结
皖公网安备34019202002308
